Herpes simplex glycoprotein DNA vaccine - Pharmadigm
Latest Information Update: 13 Jul 2001
Price :
$50 *
At a glance
- Originator Inflabloc Pharmaceuticals
- Developer Inflabloc Pharmaceuticals; Nonindustrial source
- Class Gene therapies; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Herpes simplex virus infections